Live feed07:37:56·1dSave storyANALYSTRatingvia QuantisnowPerspective Therapeutics downgraded by RBC Capital Mkts with a new price targetByQuantisnow·Wall Street's wire, on your screen.CATXPerspective Therapeutics Inc.Health CareOriginal source